Cargando…
Novel Hominid-Specific IAPP Isoforms: Potential Biomarkers of Early Alzheimer’s Disease and Inhibitors of Amyloid Formation
(1) Background and aims: Amyloidosis due to aggregation of amyloid-β (Aβ(42)) is a key pathogenic event in Alzheimer’s disease (AD), whereas aggregation of mature islet amyloid polypeptide (IAPP(37)) in human islets leads to β-cell dysfunction. The aim of this study is to uncover potential biomarker...
Autores principales: | Liu, Qing-Rong, Zhu, Min, Chen, Qinghua, Mustapic, Maja, Kapogiannis, Dimitrios, Egan, Josephine M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856209/ https://www.ncbi.nlm.nih.gov/pubmed/36671553 http://dx.doi.org/10.3390/biom13010167 |
Ejemplares similares
-
Mechanisms of Transthyretin Inhibition of IAPP Amyloid Formation
por: Wasana Jayaweera, Sanduni, et al.
Publicado: (2021) -
General Amyloid Inhibitors? A Critical Examination of the Inhibition of IAPP Amyloid Formation by Inositol Stereoisomers
por: Wang, Hui, et al.
Publicado: (2014) -
Empagliflozin Induced Ketosis, Upregulated IGF-1/Insulin Receptors and the Canonical Insulin Signaling Pathway in Neurons, and Decreased the Excitatory Neurotransmitter Glutamate in the Brain of Non-Diabetics
por: Avgerinos, Konstantinos I., et al.
Publicado: (2022) -
Structural Insight into IAPP‐Derived Amyloid Inhibitors and Their Mechanism of Action
por: Niu, Zheng, et al.
Publicado: (2020) -
A Novel Pentapeptide Inhibitor Reduces Amyloid Deposit Formation by Direct Interaction with hIAPP
por: Shi, Yue, et al.
Publicado: (2019)